SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-217411
Filing Date
2019-08-09
Accepted
2019-08-09 07:11:06
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d769352d10q.htm 10-Q 590701
2 EX-31.1 d769352dex311.htm EX-31.1 6647
3 EX-31.2 d769352dex312.htm EX-31.2 6656
4 EX-32.1 d769352dex321.htm EX-32.1 4385
  Complete submission text file 0001193125-19-217411.txt   5096273

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT orgo-20190630.xml EX-101.INS 1099904
6 XBRL TAXONOMY EXTENSION SCHEMA orgo-20190630.xsd EX-101.SCH 49077
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20190630_cal.xml EX-101.CAL 52676
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20190630_def.xml EX-101.DEF 281878
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20190630_lab.xml EX-101.LAB 395047
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20190630_pre.xml EX-101.PRE 375437
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 191011291
SIC: 2834 Pharmaceutical Preparations